LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-3.4%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.61B
AUM Growth
+$1.61B
(-18%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-14.54%
Top 10 Holdings %
Top 10 Hldgs %
19.7%
Holding
510
New
10
Increased
104
Reduced
55
Closed
293
Top Buys
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$13.2M |
| 2 |
Pinduoduo
PDD
|
$12.2M |
| 3 |
Futu Holdings
FUTU
|
$12.1M |
| 4 |
Huazhu Hotels Group
HTHT
|
$8.49M |
| 5 |
Fate Therapeutics
FATE
|
$7.52M |
Top Sells
| 1 |
InMode
INMD
|
$23.9M |
| 2 |
QuidelOrtho
QDEL
|
$14.1M |
| 3 |
Halozyme
HALO
|
$13.6M |
| 4 |
Trip.com Group
TCOM
|
$13M |
| 5 |
Amazon
AMZN
|
$12.8M |
Sector Composition
| 1 | Healthcare | 53.98% |
| 2 | Consumer Discretionary | 13.16% |
| 3 | Financials | 11.73% |
| 4 | Technology | 5.09% |
| 5 | Industrials | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
GoodRx Holdings
GDRX
$1.51B
| $41.4M | 2.57% | 1,008,901 -120,182 | -11% | -$4.93M |
|
2
Thermo Fisher Scientific
TMO
$186B
| $36M | 2.24% | 63,220 | – | – |
|
3
IQVIA
IQV
$32.4B
| $35.5M | 2.21% | 148,401 +14,838 | +11% | +$3.55M |
|
4
Tandem Diabetes Care
TNDM
$845M
| $30.7M | 1.9% | 256,856 -52,591 | -17% | -$6.28M |
|
5
Service Corp International
SCI
$11.1B
| $30.1M | 1.87% | 500,000 | – | – |
|
6
Hologic
HOLX
$14.9B
| $29.8M | 1.85% | 403,771 -2,587 | -0.6% | -$191K |
|
7
American Express
AXP
$231B
| $28.6M | 1.78% | 171,315 -36,706 | -18% | -$6.13M |
|
8
Merck
MRK
$210B
| $28.5M | 1.77% | 381,382 +6,823 | +2% | +$511K |
|
9
Labcorp
LH
$23.1B
| $28.5M | 1.77% | 101,202 +235 | +0.2% | +$66.1K |
|
|
BHVN
10
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $28.2M | 1.75% | 203,011 -67,347 | -25% | -$9.36M |
|
11
NeoGenomics
NEO
$1.13B
| $28.2M | 1.75% | 584,281 +17,820 | +3% | +$860K |
|
12
Exact Sciences
EXAS
$8.98B
| $27.8M | 1.73% | 291,301 +14,380 | +5% | +$1.37M |
|
13
Ameriprise Financial
AMP
$48.5B
| $27M | 1.67% | 102,159 | – | – |
|
14
Lowe's Companies
LOW
$145B
| $26.8M | 1.66% | 132,467 -23,509 | -15% | -$4.75M |
|
15
UnitedHealth
UNH
$281B
| $26.1M | 1.62% | 67,318 -5,555 | -8% | -$2.15M |
|
16
Keysight
KEYS
$28.1B
| $25.6M | 1.59% | 156,177 -48,478 | -24% | -$7.95M |
|
17
Visa
V
$683B
| $25.6M | 1.59% | 115,939 +2,356 | +2% | +$520K |
|
18
Voya Financial
VOYA
$7.24B
| $24.9M | 1.55% | 406,414 | – | – |
|
19
Abbott
ABT
$231B
| $24.7M | 1.53% | 209,474 -25,140 | -11% | -$2.96M |
|
20
Charles Schwab
SCHW
$174B
| $24.6M | 1.53% | 339,009 +26,488 | +8% | +$1.92M |
|
21
Thor Industries
THO
$5.79B
| $24.6M | 1.52% | 200,000 | – | – |
|
22
Brunswick
BC
$4.15B
| $24.6M | 1.52% | 258,380 +8,380 | +3% | +$796K |
|
23
Biogen
BIIB
$19.4B
| $23.8M | 1.48% | 84,346 +7,217 | +9% | +$2.04M |
|
24
Natera
NTRA
$23.1B
| $23.8M | 1.48% | 213,400 -20,068 | -9% | -$2.24M |
|
25
Teladoc Health
TDOC
$1.37B
| $23.7M | 1.47% | 187,275 +52,356 | +39% | +$6.64M |
|